Leukemia burden, shown as percentage of human CD45+CD19+, in PB was significantly decreased in SF2535-treated mice (P=0.0202) (Figure S8D) yet there was no decrease of human leukemia in BM or SPC (Figures S8B, C). The gene discussed is CD19; the disease is leukemia.